Call: (713)-840-0950 Páginas disponibles en español
L E G A L  E X C E L L E N C EC L I E N T   R E S P O N S I V E N E S SE X P E R I E N C EA C C O U N T A B I L I T Y

ZOFRAN BIRTH DEFECT LAWSUITS

The Cartwright Law Firm is investigating potential claims on behalf of mothers who were prescribed the anti-nausea medication Zofran (ondansetron) during their pregnancy and delivered children with birth defects. While Zofran was never tested or approved for use by pregnant women, it is often prescribed off-label for morning sickness and hyperemesis gravidarum, a serious type of morning sickness that causes severe nausea and weight loss. Now, recent studies have shown that expecting mothers who took Zofran are at a higher risk for delivering children with birth defects.

Birth defects linked to Zofran use during pregnancy include:
  • Heart defects, including septal defects or holes in the heart
  • Craniofacial defects, including cleft palates
  • Kidney malformations

Zofran, also known by the generic name ondansetron, has been most harmful to pregnant users. In the past, it has been prescribed frequently to expectant mothers to help treat mild to severe morning sickness. However, children born to Zofran patients have shown an alarmingly high rate of certain birth defects. If you were prescribed Zofran during pregnancy and your child suffered a birth defect, then it is time to take a serious look at your legal options.

A Troubled History for Zofran’s Manufacturer

This is not the first time GlaxoSmithKline—the manufacturer of Zofran—has been in legal trouble with this drug. Since its debut in 1991, Zofran was marketed as a way to treat nausea for patients undergoing chemotherapy, radiotherapy and surgical anesthia. However, the Department of Justice found that GlaxoSmithKline also marketed the drug for treating morning sickness, even though it had not tested the drug for safe use in pregnant women. It was also discovered that the company was offering kickbacks to doctors who helped them market the drug to their pregnant patients.

In 2012, the company was ordered to pay $3 Billion dollars to the federal government after it pleaded guilty to secretly marketing the drug specifically to treat morning sickness. The $3 billion penalty, however, was for violating government regulations—not for compensating the families and newborn children who have been affected by Zofran. In February and March 2015, the first four Zofran cases were filed in Massachusetts, Minnesota, Oakland and San Francisco, California.

Because of GlaxoSmithKline’s actions, families all over the U.S. have suffered from the harmful side effects of Zofran. If you were prescribed Zofran during your pregnancy and your child was born with a heart defect, cleft palate, kidney malformations or other defects, contact The Cartwright Law Firm immediately. You might be entitled to legal compensation.

DO NOT LET TIME RUN OUT, ACT NOW…

We offer a free initial consultation with our experienced and knowledgeable lawyers and we can make sure your family’s voice is heard during this difficult time. Use the contact form or call us today at 713-840-0950. Hablamos Español.

Click here to learn the steps you need to take to protect your legal rights.

WE WILL FIGHT FOR YOU…

For a free and confidential consultation with a drug litigation attorney who focuses on Zofran, other defective drugs and pharmaceutical litigation, click the link below or to contact us immediately call 713-840-0950. Hablamos Español.

Get a FREE no obligation consultation and find out what you can do to fight back.

Although based in Houston, our pharmaceutical drug litigation attorneys represent clients throughout Texas and the United States.